Overview
- Weippert shared that a recent follow‑up ultrasound showed the lesion in her right breast has increased in size and she posted the scan to her Instagram followers.
- Her doctors presented two options: perform a biopsy now to obtain definitive tissue results or defer invasive testing and re‑scan the lesion in six months by ultrasound.
- Clinicians offered a cautious view that the finding has features resembling a fibroadenoma, a typically benign growth, and said monitoring can be medically acceptable in such cases.
- A prior biopsy in 2024 found a separate left‑breast tumor to be benign and was left in place, and that earlier experience is shaping Weippert’s current doubts and her conversations with multiple medical advisers.
- Weippert has not decided yet and said she needs time to think, so the next steps to watch for are whether she opts for immediate biopsy or chooses short‑term surveillance and how that choice affects her care and peace of mind.